Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene

Eun Seong Hwang, David J. Riese, Jeffrey Settleman, Laura A. Nilson, Julie Honig, Stuart D Flynn, Daniel Dimaio

Research output: Contribution to journalArticle

141 Citations (Scopus)

Abstract

Human papillomavirus (HPV) E6 and E7 oncogenes are expressed in the great majority of human cervical carcinomas, whereas the viral E2 regulatory gene is usually disrupted in these cancers. To investigate the roles of the papillomavirus E2 genes in the development and maintenance of cervical carcinoma, the bovine papillomavirus (BPV) E2 gene was acutely introduced into cervical carcinoma cell lines by infection with high-titer stocks of simian virus 40-based recombinant viruses. Expression of the BPV E2 protein in HeLa, C-4I, and MS751 cells results in specific inhibition of the expression of the resident HPV type 18 (HPV18) E6 and E7 genes and in inhibition of cell growth. HeLa cells, in which HPV gene expression is nearly completely abolished, undergo a dramatic and rapid inhibition of proliferation, which appears to be largely a consequence of a block in progression from the G1 to the S phase of the cell cycle. Loss of HPV18 gene expression in HeLa cells is also accompanied by a marked increase in the level of the cellular p53 tumor suppressor protein, apparently as a consequence of abrogation of HPV18 E6-mediated destabilization of p53. The proliferation of HT-3 cells, a human cervical carcinoma cell line devoid of detectable HPV DNA, is also inhibited by E2 expression, whereas two other epithelial cell lines that do not contain HPV DNA are not inhibited. Thus, a number of cervical carcinoma cell lines are remarkably sensitive to growth inhibition by the E2 protein. Although BPV E2-mediated inhibition of HPV18 E6 and E7 expression may contribute to growth inhibition in some of the cervical carcinoma cell lines, the BPV E2 protein also appears to exert a growth-inhibitory effect that is independent of its effects on HPV gene expression.

Original languageEnglish (US)
Pages (from-to)3720-3729
Number of pages10
JournalJournal of Virology
Volume67
Issue number7
StatePublished - Jul 1993
Externally publishedYes

Fingerprint

Bovine papillomavirus
uterine cervical neoplasms
Regulator Genes
Papillomaviridae
regulator genes
cell lines
Human papillomavirus 18
Cell Proliferation
Carcinoma
Cell Line
Growth
HeLa Cells
Gene Expression
gene expression
growth retardation
Genes
Tumor Suppressor Protein p53
Simian virus 40
cells
DNA

ASJC Scopus subject areas

  • Immunology

Cite this

Hwang, E. S., Riese, D. J., Settleman, J., Nilson, L. A., Honig, J., Flynn, S. D., & Dimaio, D. (1993). Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. Journal of Virology, 67(7), 3720-3729.

Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. / Hwang, Eun Seong; Riese, David J.; Settleman, Jeffrey; Nilson, Laura A.; Honig, Julie; Flynn, Stuart D; Dimaio, Daniel.

In: Journal of Virology, Vol. 67, No. 7, 07.1993, p. 3720-3729.

Research output: Contribution to journalArticle

Hwang, ES, Riese, DJ, Settleman, J, Nilson, LA, Honig, J, Flynn, SD & Dimaio, D 1993, 'Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene', Journal of Virology, vol. 67, no. 7, pp. 3720-3729.
Hwang, Eun Seong ; Riese, David J. ; Settleman, Jeffrey ; Nilson, Laura A. ; Honig, Julie ; Flynn, Stuart D ; Dimaio, Daniel. / Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene. In: Journal of Virology. 1993 ; Vol. 67, No. 7. pp. 3720-3729.
@article{cecc3b0669524877830caa1c6e359d06,
title = "Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene",
abstract = "Human papillomavirus (HPV) E6 and E7 oncogenes are expressed in the great majority of human cervical carcinomas, whereas the viral E2 regulatory gene is usually disrupted in these cancers. To investigate the roles of the papillomavirus E2 genes in the development and maintenance of cervical carcinoma, the bovine papillomavirus (BPV) E2 gene was acutely introduced into cervical carcinoma cell lines by infection with high-titer stocks of simian virus 40-based recombinant viruses. Expression of the BPV E2 protein in HeLa, C-4I, and MS751 cells results in specific inhibition of the expression of the resident HPV type 18 (HPV18) E6 and E7 genes and in inhibition of cell growth. HeLa cells, in which HPV gene expression is nearly completely abolished, undergo a dramatic and rapid inhibition of proliferation, which appears to be largely a consequence of a block in progression from the G1 to the S phase of the cell cycle. Loss of HPV18 gene expression in HeLa cells is also accompanied by a marked increase in the level of the cellular p53 tumor suppressor protein, apparently as a consequence of abrogation of HPV18 E6-mediated destabilization of p53. The proliferation of HT-3 cells, a human cervical carcinoma cell line devoid of detectable HPV DNA, is also inhibited by E2 expression, whereas two other epithelial cell lines that do not contain HPV DNA are not inhibited. Thus, a number of cervical carcinoma cell lines are remarkably sensitive to growth inhibition by the E2 protein. Although BPV E2-mediated inhibition of HPV18 E6 and E7 expression may contribute to growth inhibition in some of the cervical carcinoma cell lines, the BPV E2 protein also appears to exert a growth-inhibitory effect that is independent of its effects on HPV gene expression.",
author = "Hwang, {Eun Seong} and Riese, {David J.} and Jeffrey Settleman and Nilson, {Laura A.} and Julie Honig and Flynn, {Stuart D} and Daniel Dimaio",
year = "1993",
month = "7",
language = "English (US)",
volume = "67",
pages = "3720--3729",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene

AU - Hwang, Eun Seong

AU - Riese, David J.

AU - Settleman, Jeffrey

AU - Nilson, Laura A.

AU - Honig, Julie

AU - Flynn, Stuart D

AU - Dimaio, Daniel

PY - 1993/7

Y1 - 1993/7

N2 - Human papillomavirus (HPV) E6 and E7 oncogenes are expressed in the great majority of human cervical carcinomas, whereas the viral E2 regulatory gene is usually disrupted in these cancers. To investigate the roles of the papillomavirus E2 genes in the development and maintenance of cervical carcinoma, the bovine papillomavirus (BPV) E2 gene was acutely introduced into cervical carcinoma cell lines by infection with high-titer stocks of simian virus 40-based recombinant viruses. Expression of the BPV E2 protein in HeLa, C-4I, and MS751 cells results in specific inhibition of the expression of the resident HPV type 18 (HPV18) E6 and E7 genes and in inhibition of cell growth. HeLa cells, in which HPV gene expression is nearly completely abolished, undergo a dramatic and rapid inhibition of proliferation, which appears to be largely a consequence of a block in progression from the G1 to the S phase of the cell cycle. Loss of HPV18 gene expression in HeLa cells is also accompanied by a marked increase in the level of the cellular p53 tumor suppressor protein, apparently as a consequence of abrogation of HPV18 E6-mediated destabilization of p53. The proliferation of HT-3 cells, a human cervical carcinoma cell line devoid of detectable HPV DNA, is also inhibited by E2 expression, whereas two other epithelial cell lines that do not contain HPV DNA are not inhibited. Thus, a number of cervical carcinoma cell lines are remarkably sensitive to growth inhibition by the E2 protein. Although BPV E2-mediated inhibition of HPV18 E6 and E7 expression may contribute to growth inhibition in some of the cervical carcinoma cell lines, the BPV E2 protein also appears to exert a growth-inhibitory effect that is independent of its effects on HPV gene expression.

AB - Human papillomavirus (HPV) E6 and E7 oncogenes are expressed in the great majority of human cervical carcinomas, whereas the viral E2 regulatory gene is usually disrupted in these cancers. To investigate the roles of the papillomavirus E2 genes in the development and maintenance of cervical carcinoma, the bovine papillomavirus (BPV) E2 gene was acutely introduced into cervical carcinoma cell lines by infection with high-titer stocks of simian virus 40-based recombinant viruses. Expression of the BPV E2 protein in HeLa, C-4I, and MS751 cells results in specific inhibition of the expression of the resident HPV type 18 (HPV18) E6 and E7 genes and in inhibition of cell growth. HeLa cells, in which HPV gene expression is nearly completely abolished, undergo a dramatic and rapid inhibition of proliferation, which appears to be largely a consequence of a block in progression from the G1 to the S phase of the cell cycle. Loss of HPV18 gene expression in HeLa cells is also accompanied by a marked increase in the level of the cellular p53 tumor suppressor protein, apparently as a consequence of abrogation of HPV18 E6-mediated destabilization of p53. The proliferation of HT-3 cells, a human cervical carcinoma cell line devoid of detectable HPV DNA, is also inhibited by E2 expression, whereas two other epithelial cell lines that do not contain HPV DNA are not inhibited. Thus, a number of cervical carcinoma cell lines are remarkably sensitive to growth inhibition by the E2 protein. Although BPV E2-mediated inhibition of HPV18 E6 and E7 expression may contribute to growth inhibition in some of the cervical carcinoma cell lines, the BPV E2 protein also appears to exert a growth-inhibitory effect that is independent of its effects on HPV gene expression.

UR - http://www.scopus.com/inward/record.url?scp=0027158747&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027158747&partnerID=8YFLogxK

M3 - Article

C2 - 8389903

AN - SCOPUS:0027158747

VL - 67

SP - 3720

EP - 3729

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 7

ER -